- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
TP53-binding protein variants and breast cancer risk: a case-control study ; volume:7 ; number:4 ; day:6 ; month:5 ; year:2005 ; pages:1-4 ; date:8.2005
Breast cancer research ; 7, Heft 4 (6.5.2005), 1-4, 8.2005
- Creator
-
Frank, Bernd
- Contributor
-
Hemminki, Kari
Bermejo, Justo Lorenzo
Klaes, Rüdiger
Bugert, Peter
Wappenschmidt, Barbara
Schmutzler, Rita K.
Burwinkel, Barbara
SpringerLink (Online service)
- DOI
-
10.1186/bcr1038
- URN
-
urn:nbn:de:1111-2016032356369
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Frank, Bernd
- Hemminki, Kari
- Bermejo, Justo Lorenzo
- Klaes, Rüdiger
- Bugert, Peter
- Wappenschmidt, Barbara
- Schmutzler, Rita K.
- Burwinkel, Barbara
- SpringerLink (Online service)
Other Objects (12)
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
MUTYH gene variants and breast cancer in a Dutch case–control study
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
Germline TP53 mutational spectrum in French Canadians with breast cancer
The R337H mutation in TP53 and breast cancer in Brazil
Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas
Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
MUTYH gene variants and breast cancer in a Dutch case–control study
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
Germline TP53 mutational spectrum in French Canadians with breast cancer
The R337H mutation in TP53 and breast cancer in Brazil
Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas
Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
MUTYH gene variants and breast cancer in a Dutch case–control study
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
Germline TP53 mutational spectrum in French Canadians with breast cancer
The R337H mutation in TP53 and breast cancer in Brazil
Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility
In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas